Search alternatives:
31 november » _ november, 4 november, 29 november
30 november » _ november, 4 november

2
Published 2016
Canadian Agency for Drugs and Technologies in Health

3
Published 2016
Canadian Agency for Drugs and Technologies in Health

11
Published 2014
Canadian Agency for Drugs and Technologies in Health
... that was specifically designed to reduce immunological reactivity. It can be rapidly administered (IV rate of 30-60...

12
Published 2014
Canadian Agency for Drugs and Technologies in Health
... that was specifically designed to reduce immunological reactivity. It can be rapidly administered (IV rate of 30-60...

13
Published 2013
Canadian Agency for Drugs and Technologies in Health
...-offs: mild, e 5 and < 15 events/hour; moderate, e 15 and < 30 events/hour; severe, e 30 events/hour....

14
Published 2013
Canadian Agency for Drugs and Technologies in Health
...-offs: mild, e 5 and < 15 events/hour; moderate, e 15 and < 30 events/hour; severe, e 30 events/hour....

15
Published 2011
Canadian Agency for Drugs and Technologies in Health
... in patients with AF by more than 60% compared with no treatment, and by 30% to 40% compared with low-dose...

16
by Tran, Khai
Published 2017
Canadian Agency for Drugs and Technologies in Health

17
Published 2019
CADTH
... hours a day or longer. Ona A is administered as a minimum of 31 injections and a maximum of 39...

18
by Tran, Khai
Published 2017
Canadian Agency for Drugs and Technologies in Health

19
Published 2019
CADTH
... hours a day or longer. Ona A is administered as a minimum of 31 injections and a maximum of 39...